Diagnostic lab unit economics in India explained

Diagnostic lab unit economics is the study of how a pathology or imaging business makes money on each test it runs, and on the whole lab once fixed costs are spread across thousands of tests. In plain words: a lab buys reagents and sample tubes, pays technicians and rent, services equipment loans, and sometimes pays a referring doctor a cut. It then bills patients, hospitals or corporates for the report. The difference between billing and all those costs, multiplied by the number of tests it can push through in a day, is the business.

India's diagnostics market runs on a wide spread of models, from large national chains to a single-pathologist neighbourhood lab to an at-home phlebotomist who visits flats and routes samples to a partner lab. Each earns differently, but the same few levers decide who makes money. Point-of-care testing is also growing at the low-cost end. BabyCue, an Odisha healthtech startup, won first prize at the Tribal Business Conclave Open Grand Challenge for its DiaCue rapid test, which according to the company gives results in 15 to 20 minutes without complex lab equipment or cold-chain storage. The award carried ₹5 lakh and was presented by President Droupadi Murmu.

What does a diagnostic lab actually sell?

A lab sells a reported result, not a machine hour. The test menu is usually split into a few buckets. Routine biochemistry and haematology tests (blood sugar, lipid profile, complete blood count, liver and kidney panels) are high-volume, low-price and heavily automated. Specialised tests (hormones, tumour markers, molecular and genetic panels, cultures) are lower-volume and higher-priced. Imaging (X-ray, ultrasound, CT, MRI) is a separate business with its own equipment economics.

Realisations differ sharply by channel. A walk-in patient paying cash may pay the list price. A corporate or insurance contract negotiates a discount. A package bundles ten tests at a price below the sum of parts to pull in volume. A doctor-referred patient may be billed at list price, but a commission goes out the back door. So the same lab can run the same test at three different net realisations.

How does the referral-doctor commission model work?

In much of Indian diagnostics, a share of the bill is paid to the doctor or clinic that referred the patient. This is often described as a commission or a professional fee, and it is the single biggest leak in a small lab's profit and loss. The practice is widely discussed in the sector and is regulated under Indian medical ethics rules, which restrict fee-splitting for referrals; enforcement varies.

What matters for unit economics is that the commission is charged on the billed amount, not on the margin. If a test is billed at a certain amount and the referral fee is 20%, the lab keeps the rest before its own costs. On a thin-margin routine test, that can wipe out the profit entirely. Labs that build direct patient relationships, own-brand packages or corporate tie-ups are effectively trying to reduce the share of revenue that leaves as referral fees.

What does a collection centre or franchise cost the lab?

Collection centres are small sample-drawing points, often in a pharmacy, clinic or standalone shop, that send samples to a main processing lab. Two models exist. In an owned model, the lab pays rent, staff and equipment. In a franchise or partner model, a local entrepreneur sets up the centre, draws samples and keeps an agreed share of the test price, while the lab processes the sample and issues the report.

For the lab, the franchise model converts a fixed cost into a variable one: it pays only when samples arrive. That helps a chain expand into smaller towns without heavy capital. The trade-off is lower margin per test and less control over the patient experience. Collection centres also need cold-chain logistics and reliable pickup routes, or samples spoil and tests are repeated at the lab's cost.

Why do fixed costs and throughput decide margins?

Most of a lab's cost base does not move with the number of tests. Equipment EMIs, rent, a pathologist's salary, quality accreditation, IT systems and a minimum technician team are largely fixed. Reagents and consumables are the main variable cost, and on automated analysers they are modest per test because machines run many samples from one reagent pack.

That creates operating leverage: once the fixed base is covered, each extra test adds mostly contribution. A machine that runs many samples a day spreads the same EMI over more tests than one running fewer. This is why lab chains chase volume through packages, home collection, corporate contracts and B2B processing for smaller labs. It is also why a half-empty lab struggles even with high list prices.

Common mistakes founders make in diagnostics:

• Pricing on competitor list prices without modelling the referral fee and discount that will actually be given.
• Buying equipment for prestige tests before the routine volume exists to fill the day.
• Treating collection centre revenue as pure profit and ignoring pickup logistics and repeat tests.
• Ignoring turnaround time, which quietly drives referral leakage to faster competitors.
• Underestimating accreditation, quality control and audit costs as a fixed overhead.

Where do at-home collection services make or lose money?

Home collection adds a phlebotomist visit, a vehicle or rider, a cold box and scheduling software. The visit cost is largely fixed per booking, so the service only works when the average order value is high enough, usually through bundled packages or multiple family members tested in one visit. Thin single-test bookings lose money on logistics. Apps solve discovery and scheduling, but they do not remove the per-visit cost.

What it means for Indian retailers

Diagnostics is a useful comparison for any retailer running fixed assets. A pharmacy adding a collection counter, a retail chain leasing space to a lab, or an entrepreneur buying a franchise is making the same bet: can I fill capacity with enough paying volume before the fixed costs eat me? Check the referral arrangements, the real net realisation after discounts, the sample pickup cost and the daily test count the equipment needs to break even. A lab's profit sits in throughput and in how little of the bill leaves as commission, not in the price printed on the test menu.